Evidence map›Paper›PMID 37672105›Full record

ArticleJournal of neurology2023

Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.

Edgar Chan, Guendalina B Bonifacio, Corin Harrison, Gargi Banerjee, Jonathan G Best, Benjamin Sacks, Nicola Harding, Maria Del Rocio Hidalgo Mas, H Rolf Jäger, Lisa Cipolotti and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Cognitive decline in Dutch-type hereditary and sporadic cerebral amyloid angiopathy: a 5-year follow-up study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Clinical Management of Cerebral Amyloid Angiopathy.Journal of clinical medicine · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Edgar ChanDepartment of Neuropsychology, National Hospital for Neurology and Neurosurgery, London, UK. edgar.chan1@nhs.net.ORCID http://orcid.org/0000-0003-2312-683X
Guendalina B BonifacioDepartment of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Corin HarrisonDepartment of Neuropsychology, National Hospital for Neurology and Neurosurgery, London, UK.
Gargi BanerjeeDepartment of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Jonathan G BestDepartment of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Benjamin SacksComprehensive Stroke Service, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Nicola HardingComprehensive Stroke Service, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Maria Del Rocio Hidalgo MasDepartment of Neuropsychology, National Hospital for Neurology and Neurosurgery, London, UK.
H Rolf JägerNeuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, UK.
Lisa CipolottiDepartment of Neuropsychology, National Hospital for Neurology and Neurosurgery, London, UK.
David J WerringDepartment of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
National Hospital for Neurology and Neurosurgery · GBStroke Association · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCerebral amyloid angiopathy (CAA) is associated with cognitive impairment, but the contributions of lobar intracerebral haemorrhage (ICH), underlying diffuse vasculopathy, and neurodegeneration, remain uncertain. We investigated the domain-specific neuropsychological profile of CAA with and without ICH, and their associations with structural neuroimaging features.

methodsData were collected from patients with possible or probable CAA attending a specialist outpatient clinic. Patients completed standardised neuropsychological assessment covering seven domains. MRI scans were scored for markers of cerebral small vessel disease and neurodegeneration. Patients were grouped into those with and without a macro-haemorrhage (CAA-ICH and CAA-non-ICH).

resultsWe included 77 participants (mean age 72, 65% male). 26/32 (81%) CAA-non-ICH patients and 41/45 (91%) CAA-ICH patients were impaired in at least one cognitive domain. Verbal IQ and non-verbal IQ were the most frequently impaired, followed by executive functions and processing speed. We found no significant differences in the frequency of impairment across domains between the two groups. Medial temporal atrophy was the imaging feature most consistently associated with cognitive impairment (both overall and in individual domains) in both univariable and multivariable analyses. DISCUSSION: Cognitive impairment is common in CAA, even in the absence of ICH, suggesting a key role for diffuse processes related to small vessel disease and/or neurodegeneration. Our findings indicate that neurodegeneration, possibly due to co-existing Alzheimer's disease pathology, may be the most important contributor. The observation that general intelligence is the most frequently affected domain suggests that CAA has a generalised rather than focal cognitive impact.

Indexed as

Alzheimer DiseaseCerebral Amyloid AngiopathyCognitive DysfunctionAgedCerebral HemorrhageFemaleHumansMagnetic Resonance ImagingMaleCerebral amyloid angiopathyCognitionDementiaNeuropsychologyStroke

Identifiers

PMID37672105
PMCPMC10632296
OpenAlexW4386467187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.